ctrl K

AI Score

Unlock

Achilles Therapeutics (ACHL)

AI Score

Unlock

1.38

0.00 (0.00%)

At close: Mar 03, 2025, 12:38 PM

Achilles Therapeutics Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	4.73M	3.69M	3.29M	778K	303.25K	n/a
Gross Profit	-4.73M	-3.69M	-3.29M	-778K	-303.25K	n/a
Operating Income	-75.25M	-78.38M	-64.19M	-33.73M	-13.78M	-6.9M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-69.17M	-71.06M	-61.06M	-33.2M	-13.99M	-6.89M
Net Income	-69.67M	-71.18M	-61.1M	-33.2M	-13.99M	-6.89M
Selling & General & Admin	12.34M	21.12M	21.97M	11.1M	4.7M	2.1M
Research & Development	67.65M	57.26M	42.22M	22.63M	9.07M	4.8M
Other Expenses	-9.4M	7.32M	3.13M	531K	-215K	n/a
Operating Expenses	75.25M	78.38M	64.19M	33.73M	13.78M	6.89M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	-4.67M	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	75.25M	78.38M	64.19M	33.73M	13.78M	6.89M
Income Tax	491K	111K	37K	3K	130.14K	n/a
Shares Outstanding (Basic)	39.97M	39.14M	28.65M	40.62M	1.64M	542K
Shares Outstanding (Diluted)	39.97M	39.14M	28.65M	40.62M	1.64M	542.59K
EPS (Basic)	-1.74	-1.82	-2.13	-0.82	-8.52	-12.71
EPS (Diluted)	-1.74	-1.82	-2.13	-0.82	-8.52	-12.69
EBITDA	-70.44M	-78.38M	-57.77M	-32.95M	-13.47M	-6.73M
Depreciation & Amortization	4.73M	3.69M	3.29M	778K	303.25K	173K